MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.39
Dividend & YieldN/A£ (N/A)
Beta 0.85
Market capitalization 6.78M
Operating cash flow -4.06M
ESG Scores unknown

Company description

MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the oil and gas, power, marine, and heavy manufacturing sectors in the Middle East, the United States, Nigeria, Australia and internationally. The company offers oil removal solutions for upstream produced water to oil companies; and hydrocarbons removal services from downstream process wastewater that are used in petrochemical facilities and refineries. It also sells or leases its equipment; and sells consumable filtration media. MYCELX Technologies Corporation was incorporated in 1994 and is headquartered in Norcross, Georgia.

Sector: Industrials - Industry: Pollution & Treatment Controls

Financial Ratios
Quick Ratio1.55
Working Capital-0.8
Return On Equity-0.44
Debt To Equity0.11
Fixed Asset Ratio0.05
Fixed Interest Cover-51.74

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 1.87M -2.25M 432k -481k
Total Cashflows From Investing Activities -515k -867k -159k 5.08M
Net Borrowings -96k -86k 1.3M -2.24M
Total Cash From Financing Activities -88k 1.54M 1.3M -2.24M
Change To Operating Activities 1.53M -1.11M 89k -571k
Issuance Of Stock 8k 1.63M
Net Income 3.07M -2.96M -6.09M -1.43M
Change In Cash -305k -1.24M -355k -580k
Effect Of Exchange Rate
Total Cash From Operating Activities 298k -1.92M -1.5M -3.43M
Depreciation 1.24M 1.27M 1.43M 1.12M
Change To Account Receivables -5.41M 4.26M 2.51M -563k
Other Cashflows From Financing Activities
Change To Netincome 83k 380k 702k -2.77M
Capital Expenditures -492k -805k -110k -327k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 352k 352k 64k 223k
Income Before Tax 4.27M -2.5M -5.77M -1.13M
Net Income 3.07M -2.96M -6.09M -1.43M
Selling General Administrative 9.26M 7.75M 7.27M 6.94M
Gross Profit 14.06M 6.09M 1.59M 3.27M
Ebit 4.36M -2.41M -6.05M -4.09M
Operating Income 4.36M -2.41M -6.05M -4.09M
Interest Expense -85k -80k -117k -24k
Income Tax Expense 1.2M 460k 328k 296k
Total Revenue 26.95M 11.91M 7.1M 8.48M
Cost Of Revenue 12.89M 5.82M 5.51M 5.2M
Total Other Income ExpenseNet -88k -93k 287k 2.96M
Net Income From Continuing Ops 3.07M -2.96M -6.09M -1.43M
Net Income Applicable To Common Shares 3.07M -2.96M -6.09M -1.43M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 6.96M 4.66M 5.34M 3.04M
Total Stockholder Equity 20.97M 19.84M 13.79M 12.62M
Other Current Liabilities 278k 864k 1.24M 128k
Total Assets 27.94M 24.5M 19.13M 15.66M
Common Stock 470k 486k 486k 486k
Other Current Assets 567k 887k 607k 483k
Retained Earnings -20.04M -23M -29.09M -30.52M
Treasury Stock
Cash 4.87M 3.65M 3.29M 3.13M
Total Current Liabilities 5.23M 2.53M 3.52M 1.82M
Other Stockholder Equity
Property, Plant, and Equipment 8.54M 8.82M 7.24M 4.71M
Total Current Assets 18.61M 14.88M 11.1M 10.18M
Net Tangible Assets 20.18M 19.05M 13M 11.85M
Net Receivables 8.24M 3.99M 1.48M 2.04M
Accounts Payable 2.91M 786k 473k 683k


Insider Transactions

Here are the insider transactions of stock shares related to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Slater (Nicholas)D2022-09-02147.37k
Mixon (Connie)D2022-05-16
Octopus Investments LtdD2022-05-16
Hargreave Hale LtdD2022-05-16
Lamb (Tom)D2022-05-16
Schnabl (Andre)D2022-05-16
Alper (Haluk)D2022-05-16
Artemis Investment Management LLPD2022-05-16
Octopus Investments LtdD2022-03-212.05M
Slater (Nicholas)D2022-03-16192.95k
Slater (Nicholas)D2022-01-28148.77k
Slater (Nicholas)D2021-11-19244.36k
Alper (Haluk)Decrease at price 0.94 per share.D2021-11-1022.5k
Lamb (Thomas B)Bought at price 0.96 per share.D2021-11-1025k
Mixon (Connie)Bought at price 0.81 per share.D2021-11-0924k
Alper (Haluk)Sold at price 0.98 per share.D2021-11-0120k
Slater (Nicholas)D2021-08-0624.61k
Eggar (Timothy John Crommelin)D2021-05-25
Octopus Investments LtdD2021-05-25
Mixon (Connie)D2021-05-25
Schnabl (Andre)D2021-05-25
Hargreave Hale LtdD2021-05-25
Artemis Investment Management LLPD2021-05-25
Alper (Haluk)D2021-05-25
Slater (Nicholas)D2021-03-16
Artemis Investment Management LLPD2021-03-161.09M
Artemis Investment Management LLPD2021-03-11106.09k
Artemis Investment Management LLPD2021-02-15270.25k
Artemis Investment Management LLPD2021-01-04186.15k
Artemis Investment Management LLPD2020-12-30220.31k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

Here is the result of two systematic investment strategies applied to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

The following chart shows the equity curve of the two systematic investment strategies applied to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (:

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 22.59% on the backtest period.

Performance at glance

Performance

22.59 %

Latent gain

370.85 £

Invested capital

1641.65 £

Annualized return

5.51 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

This is the result of two momentum investment strategies applied to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

The following chart shows all the entries opened by the momentum investment system on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (:

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( momentum entries
  • The first momentum investment strategy would give 26.94% of return on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (. That represents 1513.05£ of latent gain with 5616.95£ of employed capital.
  • The second momentum investment strategy would give 21.58% of return on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (. That represents 530.7£ of latent gain with 2459.3£ of employed capital.
Performance at glance (1Q Momentum)

Performance

26.94 %

Latent gain

1513.05 £

Invested capital

5616.95 £

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

21.58 %

Latent gain

530.7 £

Invested capital

2459.3 £

Annualized return

5.96 %

Momentum equity curve on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

The following chart shows the equity curve of the two momentum strategies applied to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (:

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( momentum equity

Note: the dividends potentially given by MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

The following chart shows the employed capital evolution of the two momentum strategies on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( since the beginning:

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

Buy the dip entry openings on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

The performance achieved by the robo-advisor on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

0.0 %

Equity curve of the strategy applied to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

The following chart shows the result of the investment strategy applied to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (:

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

Note: the dividends potentially given by MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

The following chart shows the employed capital evolution since the beginning of the investment strategy on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (:

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

In this section, I will compare the three previous investment strategies applied to MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (.

Equity curve comparison on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( investment strategy comparison

Employed capital comparison on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( investment comparison

Performance comparison on MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 22.59% 370.85£ 1641.65£ 5.51%
Momentum 1 quarter 26.94% 1513.05£ 5616.95£ 6.98%
Momentum 2 quarters 21.58% 530.7£ 2459.3£ 5.96%
Non-directional 0% 0.0£ 0.0£ 0.0%
Annualized return comparison

Automatic investment

5.51 %

Momentum 1Q

5.96 %

Momentum 2Q

5.96 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( and the other stocks. There may be false positives or some missing correlated stocks. If the price of MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 (
Country United States
City Norcross
Address 1650 International Court
Phone 770 534 3118
Website www.mycelx.com
FullTime employees
Industry Pollution & Treatment Controls
Sector Industrials
Exchange XLON
Ticker MYX.XLON
Market www.londonstockexchange.com

MYCELX TECHNOLOGIES CORPORATION COM SHS USD0.025 ( ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown